Ingrid Øra

5.6k total citations
81 papers, 2.6k citations indexed

About

Ingrid Øra is a scholar working on Neurology, Molecular Biology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Ingrid Øra has authored 81 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in Neurology, 28 papers in Molecular Biology and 18 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Ingrid Øra's work include Neuroblastoma Research and Treatments (43 papers), Childhood Cancer Survivors' Quality of Life (14 papers) and Cancer, Hypoxia, and Metabolism (13 papers). Ingrid Øra is often cited by papers focused on Neuroblastoma Research and Treatments (43 papers), Childhood Cancer Survivors' Quality of Life (14 papers) and Cancer, Hypoxia, and Metabolism (13 papers). Ingrid Øra collaborates with scholars based in Sweden, Netherlands and United States. Ingrid Øra's co-authors include Sven Påhlman, Rogier Versteeg, Jan Köster, Angelika Eggert, David Gisselsson, Håkan Axelson, Helén Nilsson, Annika Jögi, Lorenz Poellinger and Yuichi Makino and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and Nature Genetics.

In The Last Decade

Ingrid Øra

79 papers receiving 2.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ingrid Øra Sweden 28 1.5k 900 801 537 303 81 2.6k
R P Castleberry United States 23 1.2k 0.8× 2.1k 2.3× 715 0.9× 382 0.7× 242 0.8× 36 2.7k
Béatrice Parfait France 30 1.5k 1.0× 833 0.9× 629 0.8× 295 0.5× 421 1.4× 83 3.3k
Jerry J. Jaboin United States 25 869 0.6× 421 0.5× 237 0.3× 457 0.9× 350 1.2× 110 2.2k
Anthony P. Heaney United States 39 1.6k 1.0× 908 1.0× 929 1.2× 1.1k 2.0× 175 0.6× 122 5.7k
Peter E. Zage United States 25 1.0k 0.7× 837 0.9× 460 0.6× 348 0.6× 108 0.4× 64 1.7k
Agnès Ribeiro France 27 1.3k 0.9× 1.0k 1.1× 662 0.8× 704 1.3× 339 1.1× 49 2.7k
Barbara Pasini Italy 34 2.0k 1.3× 484 0.5× 900 1.1× 1.1k 2.0× 603 2.0× 92 5.4k
Christopher M. Heaphy United States 31 1.0k 0.7× 355 0.4× 586 0.7× 965 1.8× 608 2.0× 99 2.9k
Tatsuro Tajiri Japan 22 638 0.4× 547 0.6× 317 0.4× 358 0.7× 293 1.0× 140 1.6k
Lin Pei United States 24 1.3k 0.9× 225 0.3× 478 0.6× 488 0.9× 217 0.7× 48 2.6k

Countries citing papers authored by Ingrid Øra

Since Specialization
Citations

This map shows the geographic impact of Ingrid Øra's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ingrid Øra with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ingrid Øra more than expected).

Fields of papers citing papers by Ingrid Øra

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ingrid Øra. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ingrid Øra. The network helps show where Ingrid Øra may publish in the future.

Co-authorship network of co-authors of Ingrid Øra

This figure shows the co-authorship network connecting the top 25 collaborators of Ingrid Øra. A scholar is included among the top collaborators of Ingrid Øra based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ingrid Øra. Ingrid Øra is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Feldreich, Tobias, Constance G. Weismann, Ingrid Øra, et al.. (2024). Circulating leptin is associated with adverse vascular changes in young adult survivors of childhood cancer. Cardiology in the Young. 34(6). 1325–1333. 1 indexed citations
2.
Djos, Anna, Johanna Svensson, Ganesh Umapathy, et al.. (2024). Loss of Chromosome Y in Neuroblastoma Is Associated With High‐Risk Disease, 11q‐Deletion, and Telomere Maintenance. Genes Chromosomes and Cancer. 63(7). e23260–e23260. 2 indexed citations
3.
Øra, Ingrid, et al.. (2023). Childhood Cancer Survivors Have Impaired Strain-Derived Myocardial Contractile Reserve by Dobutamine Stress Echocardiography. Journal of Clinical Medicine. 12(8). 2782–2782. 3 indexed citations
4.
Bontell, Thomas Olsson, Helene Sjögren, Henrik Fagman, et al.. (2021). Discovery of a rare GKAP1-NTRK2 fusion in a pediatric low-grade glioma, leading to targeted treatment with TRK-inhibitor larotrectinib. Cancer Biology & Therapy. 22(3). 184–195. 8 indexed citations
5.
Øra, Ingrid, et al.. (2021). Characterization of Cardiac, Vascular, and Metabolic Changes in Young Childhood Cancer Survivors. Frontiers in Pediatrics. 9. 764679–764679. 7 indexed citations
6.
Mitra, Shamik, Linda Magnusson, Paul Piccinelli, et al.. (2021). Amplification of ERBB2 (HER2) in embryonal rhabdomyosarcoma: A potential treatment target in rare cases?. Genes Chromosomes and Cancer. 61(1). 5–9. 2 indexed citations
7.
Øra, Ingrid, et al.. (2021). Cognitive Fatigue and Processing Speed in Children Treated for Brain Tumours. Journal of the International Neuropsychological Society. 27(9). 865–874. 10 indexed citations
8.
Karlsson, Jenny, Anders Valind, Linda Holmquist Mengelbier, et al.. (2018). Four evolutionary trajectories underlie genetic intratumoral variation in childhood cancer. Nature Genetics. 50(7). 944–950. 46 indexed citations
9.
Valind, Anders, Ingrid Øra, Fredrik Mertens, & David Gisselsson. (2018). Neuroblastoma with flat genomic profile: a question of representativity?. BMJ Case Reports. 2018. bcr–2018.
10.
Stedingk, Kristoffer von, Jan Köster, Marta Piqueras, et al.. (2013). snoRNPs Regulate Telomerase Activity in Neuroblastoma and Are Associated with Poor Prognosis. Translational Oncology. 6(4). 447–IN6. 22 indexed citations
11.
Øra, Ingrid, Attila Frigyesi, Victoria Castel, et al.. (2011). Alternative lengthening of telomeres—An enhanced chromosomal instability in aggressive non‐MYCN amplified and telomere elongated neuroblastomas. Genes Chromosomes and Cancer. 50(4). 250–262. 29 indexed citations
12.
Øra, Ingrid & Angelika Eggert. (2011). Progress in treatment and risk stratification of neuroblastoma: Impact on future clinical and basic research. Seminars in Cancer Biology. 21(4). 217–228. 61 indexed citations
13.
Mengelbier, Linda Holmquist, Jenny Karlsson, David Lindgren, et al.. (2010). Deletions of 16q in Wilms Tumors Localize to Blastemal-Anaplastic Cells and Are Associated with Reduced Expression of the IRXB Renal Tubulogenesis Gene Cluster. American Journal Of Pathology. 177(5). 2609–2621. 12 indexed citations
14.
Gisselsson, David, David Lindgren, Linda Holmquist Mengelbier, Ingrid Øra, & Herman Yeger. (2010). Genetic bottlenecks and the hazardous game of population reduction in cell line based research. Experimental Cell Research. 316(20). 3379–3386. 5 indexed citations
15.
Schulte, Johannes H., Soyoung Lim, Alexander Schramm, et al.. (2009). Lysine-Specific Demethylase 1 Is Strongly Expressed in Poorly Differentiated Neuroblastoma: Implications for Therapy. Cancer Research. 69(5). 2065–2071. 369 indexed citations
16.
Jin, Yuesheng, Ingrid Øra, Ioannis Panagopoulos, et al.. (2008). High‐resolution molecular cytogenetic analysis of Wilms tumors highlights diagnostic difficulties among small round cell kidney tumors. Genes Chromosomes and Cancer. 47(10). 845–852. 10 indexed citations
17.
Paulsson, Kajsa, Tord Jonson, Ingrid Øra, et al.. (2007). Characterisation of genomic translocation breakpoints and identification of an alternative TCF3/PBX1 fusion transcript in t(1;19)(q23;p13)‐positive acute lymphoblastic leukaemias. British Journal of Haematology. 138(2). 196–201. 17 indexed citations
18.
Revet, Ingrid, Alvin Chan, Jan Köster, et al.. (2007). The MSX1 homeobox transcription factor is a downstream target of PHOX2B and activates the Delta–Notch pathway in neuroblastoma. Experimental Cell Research. 314(4). 707–719. 65 indexed citations
19.
Koppen, Arjen, Jan Köster, Ingrid Øra, et al.. (2007). Dickkopf‐3 expression is a marker for neuroblastic tumor maturation and is down‐regulated by MYCN. International Journal of Cancer. 122(7). 1455–1464. 32 indexed citations
20.
Gisselsson, David, et al.. (2007). Distinct evolutionary mechanisms for genomic imbalances in high-risk and low-risk neuroblastomas. Journal of Carcinogenesis. 6(1). 15–15. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by R P Castleberry Breakdown of academic impact, for papers by Béatrice Parfait Breakdown of academic impact, for papers by Jerry J. Jaboin Breakdown of academic impact, for papers by Anthony P. Heaney Breakdown of academic impact, for papers by Peter E. Zage Breakdown of academic impact, for papers by Agnès Ribeiro Breakdown of academic impact, for papers by Barbara Pasini Breakdown of academic impact, for papers by Christopher M. Heaphy Breakdown of academic impact, for papers by Tatsuro Tajiri Breakdown of academic impact, for papers by Lin Pei
Rankless by CCL
2026